106 related articles for article (PubMed ID: 16772165)
1. Tracking in the Wlds--the hunting of the SIRT and the luring of the Draper.
Fainzilber M; Twiss JL
Neuron; 2006 Jun; 50(6):819-21. PubMed ID: 16772165
[TBL] [Abstract][Full Text] [Related]
2. WldS but not Nmnat1 protects dopaminergic neurites from MPP+ neurotoxicity.
Antenor-Dorsey JA; O'Malley KL
Mol Neurodegener; 2012 Feb; 7():5. PubMed ID: 22315973
[TBL] [Abstract][Full Text] [Related]
3. The Drosophila cell corpse engulfment receptor Draper mediates glial clearance of severed axons.
MacDonald JM; Beach MG; Porpiglia E; Sheehan AE; Watts RJ; Freeman MR
Neuron; 2006 Jun; 50(6):869-81. PubMed ID: 16772169
[TBL] [Abstract][Full Text] [Related]
4. Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.
Mack TG; Reiner M; Beirowski B; Mi W; Emanuelli M; Wagner D; Thomson D; Gillingwater T; Court F; Conforti L; Fernando FS; Tarlton A; Andressen C; Addicks K; Magni G; Ribchester RR; Perry VH; Coleman MP
Nat Neurosci; 2001 Dec; 4(12):1199-206. PubMed ID: 11770485
[TBL] [Abstract][Full Text] [Related]
5. The Wlds transgene reduces axon loss in a Charcot-Marie-Tooth disease 1A rat model and nicotinamide delays post-traumatic axonal degeneration.
Meyer zu Horste G; Miesbach TA; Muller JI; Fledrich R; Stassart RM; Kieseier BC; Coleman MP; Sereda MW
Neurobiol Dis; 2011 Apr; 42(1):1-8. PubMed ID: 21168501
[TBL] [Abstract][Full Text] [Related]
6. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration.
Araki T; Sasaki Y; Milbrandt J
Science; 2004 Aug; 305(5686):1010-3. PubMed ID: 15310905
[TBL] [Abstract][Full Text] [Related]
7. A local mechanism mediates NAD-dependent protection of axon degeneration.
Wang J; Zhai Q; Chen Y; Lin E; Gu W; McBurney MW; He Z
J Cell Biol; 2005 Aug; 170(3):349-55. PubMed ID: 16043516
[TBL] [Abstract][Full Text] [Related]
8. Protection of vincristine-induced neuropathy by WldS expression and the independence of the activity of Nmnat1.
Watanabe M; Tsukiyama T; Hatakeyama S
Neurosci Lett; 2007 Jan; 411(3):228-32. PubMed ID: 17113230
[TBL] [Abstract][Full Text] [Related]
9. Local axonal protection by WldS as revealed by conditional regulation of protein stability.
Wang JT; Medress ZA; Vargas ME; Barres BA
Proc Natl Acad Sci U S A; 2015 Aug; 112(33):10093-100. PubMed ID: 26209654
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide mononucleotide adenylyl transferase-mediated axonal protection requires enzymatic activity but not increased levels of neuronal nicotinamide adenine dinucleotide.
Sasaki Y; Vohra BP; Lund FE; Milbrandt J
J Neurosci; 2009 Apr; 29(17):5525-35. PubMed ID: 19403820
[TBL] [Abstract][Full Text] [Related]
11. NAD(+) and axon degeneration revisited: Nmnat1 cannot substitute for Wld(S) to delay Wallerian degeneration.
Conforti L; Fang G; Beirowski B; Wang MS; Sorci L; Asress S; Adalbert R; Silva A; Bridge K; Huang XP; Magni G; Glass JD; Coleman MP
Cell Death Differ; 2007 Jan; 14(1):116-27. PubMed ID: 16645633
[TBL] [Abstract][Full Text] [Related]
12. Wlds protection distinguishes axon degeneration following injury from naturally occurring developmental pruning.
Hoopfer ED; McLaughlin T; Watts RJ; Schuldiner O; O'Leary DD; Luo L
Neuron; 2006 Jun; 50(6):883-95. PubMed ID: 16772170
[TBL] [Abstract][Full Text] [Related]
13. The neuroprotective WldS gene regulates expression of PTTG1 and erythroid differentiation regulator 1-like gene in mice and human cells.
Gillingwater TH; Wishart TM; Chen PE; Haley JE; Robertson K; MacDonald SH; Middleton S; Wawrowski K; Shipston MJ; Melmed S; Wyllie DJ; Skehel PA; Coleman MP; Ribchester RR
Hum Mol Genet; 2006 Feb; 15(4):625-35. PubMed ID: 16403805
[TBL] [Abstract][Full Text] [Related]
14. NAD and axon degeneration: from the Wlds gene to neurochemistry.
Wang J; He Z
Cell Adh Migr; 2009; 3(1):77-87. PubMed ID: 19372760
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms in the initiation phase of Wallerian degeneration.
Chang B; Quan Q; Lu S; Wang Y; Peng J
Eur J Neurosci; 2016 Aug; 44(4):2040-8. PubMed ID: 27062141
[TBL] [Abstract][Full Text] [Related]
16. Modified cell cycle status in a mouse model of altered neuronal vulnerability (slow Wallerian degeneration; Wlds).
Wishart TM; Pemberton HN; James SR; McCabe CJ; Gillingwater TH
Genome Biol; 2008; 9(6):R101. PubMed ID: 18570652
[TBL] [Abstract][Full Text] [Related]
17. Axon degeneration: where the Wlds things are.
Wang JT; Barres BA
Curr Biol; 2012 Apr; 22(7):R221-3. PubMed ID: 22497934
[TBL] [Abstract][Full Text] [Related]
18. WldS can delay Wallerian degeneration in mice when interaction with valosin-containing protein is weakened.
Beirowski B; Morreale G; Conforti L; Mazzola F; Di Stefano M; Wilbrey A; Babetto E; Janeckova L; Magni G; Coleman MP
Neuroscience; 2010 Mar; 166(1):201-11. PubMed ID: 20018231
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of initiation and regulation of axonal degeneration with special reference to NMNATs and Sarm1.
Funakoshi M; Araki T
Neurosci Res; 2023 Dec; 197():3-8. PubMed ID: 34767875
[TBL] [Abstract][Full Text] [Related]
20. Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.
Conforti L; Janeckova L; Wagner D; Mazzola F; Cialabrini L; Di Stefano M; Orsomando G; Magni G; Bendotti C; Smyth N; Coleman M
FEBS J; 2011 Aug; 278(15):2666-79. PubMed ID: 21615689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
